Innocan Pharma (INNPF) Revenue (2024 - 2025)
Innocan Pharma (INNPF) posted Revenue of $4.99 million for the quarter ended Dec 31, 2025, down 7.6% from $5.4 million a year earlier and down 26.9% from the prior quarter.
Powered by 
Analysis
Innocan Pharma (INNPF) Revenue (2024 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Innocan Pharma's Revenue came in at $26.61 million, down 9.6% from the prior year.
- In prior years, Innocan Pharma's Revenue was $29.44 million in the year ended Dec 31, 2024 (+115.5%) and $13.66 million in the year ended Dec 31, 2023.
- The figure for the quarter ended Dec 31, 2025 stands as the lowest quarterly Revenue in data going back to the quarter ended Mar 31, 2024.
- On a year-over-year basis, Revenue has declined in each of the last three quarters, with an average decline of 8.1% over the last four quarters.
- According to Business Quant data, Revenue for the three prior quarters was $6.82 million (quarter ended Sep 30, 2025), $7.01 million (quarter ended Jun 30, 2025) and $7.8 million (quarter ended Mar 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 24.40 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 25.40 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 17.40 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 18.09 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 15.07 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 10.37 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 8.30 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 16.58 Bn |
| 10 | Innocan Pharma | 5.78 Mn | 1.73 Mn | 4.43 Mn | 4.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.99 Mn |
| Sep 30, 2025 | 6.82 Mn |
| Jun 30, 2025 | 7.01 Mn |
| Mar 31, 2025 | 7.80 Mn |
| Dec 31, 2024 | 5.40 Mn |
| Sep 30, 2024 | 8.62 Mn |
| Jun 30, 2024 | 8.64 Mn |
| Mar 31, 2024 | 6.77 Mn |
API Access
Innocan Pharma Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=INNPF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "INNPF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=INNPF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();